1. Home
  2. KGEI vs STXS Comparison

KGEI vs STXS Comparison

Compare KGEI & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KGEI

Kolibri Global Energy Inc.

HOLD

Current Price

$5.36

Market Cap

191.0M

Sector

N/A

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.84

Market Cap

190.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KGEI
STXS
Founded
2008
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.0M
190.6M
IPO Year
2009
2004

Fundamental Metrics

Financial Performance
Metric
KGEI
STXS
Price
$5.36
$1.84
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.00
AVG Volume (30 Days)
219.9K
347.1K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
$32.37
$28.22
Revenue Next Year
$4.72
$30.47
P/E Ratio
$7.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.35
$1.70
52 Week High
$8.27
$3.59

Technical Indicators

Market Signals
Indicator
KGEI
STXS
Relative Strength Index (RSI) 47.56 45.99
Support Level $5.07 $1.73
Resistance Level $5.88 $1.99
Average True Range (ATR) 0.30 0.09
MACD -0.03 -0.01
Stochastic Oscillator 42.61 22.86

Price Performance

Historical Comparison
KGEI
STXS

About KGEI Kolibri Global Energy Inc.

Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: